Archroma unveils the NTR Printing System, the “first” commercially viable bio-based pigment printing solution that uses ...

Nuvation Bio's Taletrectinib shows promising data in phase 2 trials for ROS1-positive NSCLC. Find out my recommendation on ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Bio-Rad Laboratories, Inc. BIO is scheduled to release third-quarter 2024 results on Oct. 30, after the closing bell. The ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

Mariahlynn is an American songwriter, rapper and reality TV star widely recognised for starring in Love & Hip Hop: New York.

The FDA’s clearance for Annovis Bio to advance into Phase 3 trials after successful Phase 2 results in Alzheimer’s patients is a significant milestone. This regulatory clarity supports the ...

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage biopharmaceutical ...

The specialty chemical company introduced this week NTR Printing System for commercial bio-based pigment printing. The result ...

After hours: October 18 at 7:34 PM EDT Loading Chart for ACET ...

TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery ...

Unlock the future of diagnostics with the Immunohistochemistry market, projected to soar from $3.1 billion in 2023 to $5.5 billion by 2031, growing at a robust 7.4% CAGR! Experience innovation across ...